Electron microscopic alterations in intermediate hepatocyte-like cells in children with chronic hepatitis B: the

Joanna M Lotowska1, Maria E Sobaniec-Lotowska, Dariusz M Lebensztejn

  • 1Departments of General Pathomorphology, Medical University of Bialystok, Poland.

Insights

Chronic hepatitis B in children with fibrosis may promote degenerating intermediate hepatocyte-like cells (IHCs) toward cancer. This ultrastructural study reveals IHC damage linked to fibrosis in pediatric chronic hepatitis B patients.

Area of Science:

  • Hepatology
  • Cell Biology
  • Virology

Background:

  • Chronic hepatitis B viral (HBV) infection is a significant global health concern.
  • Liver progenitor/oval cells, including intermediate hepatocyte-like cells (IHCs), play a role in liver regeneration and disease.
  • Understanding cellular changes in pediatric chronic HBV is crucial for long-term outcomes.

Purpose of the Study:

  • To perform an in-depth ultrastructural analysis of intermediate hepatocyte-like cells (IHCs).
  • To investigate the changes in IHCs in children with chronic hepatitis B viral (HBV) infection.
  • To correlate IHC ultrastructural alterations with liver fibrosis severity.

Main Methods:

  • Ultrastructural investigation using transmission electron microscopy.
  • Analysis of liver biopsy samples from 40 children (aged 3-16 years) with chronic hepatitis B.
  • Sample preparation involved fixation in glutaraldehyde, paraformaldehyde, and cacodylate buffer.

Main Results:

  • Identified IHCs with significant ultrastructural changes, including degeneration, particularly in patients with advanced liver fibrosis.
  • Observed abnormalities in mitochondria (swelling, crest loss, myelin figures) and granular endoplasmic reticulum (shortening, degranulation) within degenerating IHCs.
  • Found primitive phagosome-like structures with biliary pigment and transitional hepatic stellate cells near altered IHCs.

Conclusions:

  • Chronic HBV infection with significant fibrosis in childhood may predispose degenerating IHCs to neoplastic transformation in adulthood.
  • Further research is needed to explore the role of coexisting carcinogenic factors.
  • These findings highlight potential long-term risks associated with pediatric chronic HBV and fibrosis.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...